These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 20607500)

  • 21. Absence of MyD88 results in enhanced TLR3-dependent phosphorylation of IRF3 and increased IFN-β and RANTES production.
    Siednienko J; Gajanayake T; Fitzgerald KA; Moynagh P; Miggin SM
    J Immunol; 2011 Feb; 186(4):2514-22. PubMed ID: 21248248
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phenethyl isothiocyanate regulates inflammation through suppression of the TRIF-dependent signaling pathway of Toll-like receptors.
    Park HJ; Kim SJ; Park SJ; Eom SH; Gu GJ; Kim SH; Youn HS
    Life Sci; 2013 Apr; 92(13):793-8. PubMed ID: 23454169
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SHP-2 phosphatase negatively regulates the TRIF adaptor protein-dependent type I interferon and proinflammatory cytokine production.
    An H; Zhao W; Hou J; Zhang Y; Xie Y; Zheng Y; Xu H; Qian C; Zhou J; Yu Y; Liu S; Feng G; Cao X
    Immunity; 2006 Dec; 25(6):919-28. PubMed ID: 17157040
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Toll-like receptor stimulation induces airway hyper-responsiveness to bradykinin, an effect mediated by JNK and NF-kappa B signaling pathways.
    Bachar O; Adner M; Uddman R; Cardell LO
    Eur J Immunol; 2004 Apr; 34(4):1196-207. PubMed ID: 15048731
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TRIF-mediated TLR3 and TLR4 signaling is negatively regulated by ADAM15.
    Ahmed S; Maratha A; Butt AQ; Shevlin E; Miggin SM
    J Immunol; 2013 Mar; 190(5):2217-28. PubMed ID: 23365087
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of homodimerization of toll-like receptor 4 by 4-oxo-4-(2-oxo-oxazolidin-3-yl)-but-2-enoic acid ethyl ester.
    Park SJ; Kang SH; Kang YK; Eom YB; Koh KO; Kim DY; Youn HS
    Int Immunopharmacol; 2011 Jan; 11(1):19-22. PubMed ID: 20939996
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Suppression of TLRs signaling pathways by 1-[5-methoxy-2-(2-nitrovinyl)phenyl]pyrrolidine.
    Ahn SI; Kim JS; Shin HM; Kim AY; Gu GJ; Shim HJ; Kim YJ; Koh KO; Mang JY; Kim DY; Youn HS
    Int Immunopharmacol; 2016 Jun; 35():193-200. PubMed ID: 27064546
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD300F blocks both MyD88 and TRIF-mediated TLR signaling through activation of Src homology region 2 domain-containing phosphatase 1.
    Lee SM; Kim EJ; Suk K; Lee WH
    J Immunol; 2011 Jun; 186(11):6296-303. PubMed ID: 21536801
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Toll-like receptor 3-mediated activation of NF-kappaB and IRF3 diverges at Toll-IL-1 receptor domain-containing adapter inducing IFN-beta.
    Jiang Z; Mak TW; Sen G; Li X
    Proc Natl Acad Sci U S A; 2004 Mar; 101(10):3533-8. PubMed ID: 14982987
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phosphatase PTP1B negatively regulates MyD88- and TRIF-dependent proinflammatory cytokine and type I interferon production in TLR-triggered macrophages.
    Xu H; An H; Hou J; Han C; Wang P; Yu Y; Cao X
    Mol Immunol; 2008 Aug; 45(13):3545-52. PubMed ID: 18571728
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Signal regulatory protein alpha negatively regulates both TLR3 and cytoplasmic pathways in type I interferon induction.
    Dong LW; Kong XN; Yan HX; Yu LX; Chen L; Yang W; Liu Q; Huang DD; Wu MC; Wang HY
    Mol Immunol; 2008 Jun; 45(11):3025-35. PubMed ID: 18471880
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanism of inhibition of lipopolysaccharide-induced interferon-β production by 2-aminopurine.
    Sugiyama T; Gotou T; Moriyama K; Kajiura N; Hasegawa T; Tomida J; Takahashi K; Komatsu T; Ueda H; Sato K; Tokoro S; Neri P; Mori H
    Mol Immunol; 2012 Oct; 52(3-4):299-304. PubMed ID: 22750230
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The mechanism of LPS-induced HIV type I activation in transgenic mouse macrophages.
    Kadoki M; Choi BI; Iwakura Y
    Int Immunol; 2010 Jun; 22(6):469-78. PubMed ID: 20504885
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TBK1-targeted suppression of TRIF-dependent signaling pathway of Toll-like receptors by 6-shogaol, an active component of ginger.
    Park SJ; Lee MY; Son BS; Youn HS
    Biosci Biotechnol Biochem; 2009 Jul; 73(7):1474-8. PubMed ID: 19584560
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of lipopolysaccharide-inducible genes by MyD88 and Toll/IL-1 domain containing adaptor inducing IFN-beta.
    Hirotani T; Yamamoto M; Kumagai Y; Uematsu S; Kawase I; Takeuchi O; Akira S
    Biochem Biophys Res Commun; 2005 Mar; 328(2):383-92. PubMed ID: 15694359
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Parthenolide inhibits TRIF-dependent signaling pathway of Toll-like receptors in RAW264.7 macrophages.
    Park SJ; Shin HJ; Youn HS
    Mol Cells; 2011 Mar; 31(3):261-5. PubMed ID: 21347702
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TICAM-1, an adaptor molecule that participates in Toll-like receptor 3-mediated interferon-beta induction.
    Oshiumi H; Matsumoto M; Funami K; Akazawa T; Seya T
    Nat Immunol; 2003 Feb; 4(2):161-7. PubMed ID: 12539043
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Toll-like receptor 3-elicited MAPK activation induces stabilization of interferon-β mRNA.
    Johnsen IB; Nguyen TT; Bergstrøm B; Lien E; Anthonsen MW
    Cytokine; 2012 Mar; 57(3):337-46. PubMed ID: 22200507
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Scaffolding adaptor protein Gab1 is required for TLR3/4- and RIG-I-mediated production of proinflammatory cytokines and type I IFN in macrophages.
    Zheng Y; An H; Yao M; Hou J; Yu Y; Feng G; Cao X
    J Immunol; 2010 Jun; 184(11):6447-56. PubMed ID: 20435932
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The human adaptor SARM negatively regulates adaptor protein TRIF-dependent Toll-like receptor signaling.
    Carty M; Goodbody R; Schröder M; Stack J; Moynagh PN; Bowie AG
    Nat Immunol; 2006 Oct; 7(10):1074-81. PubMed ID: 16964262
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.